Targeted mass spectrometry

Definition
Targeted mass spectrometry (often abbreviated as targeted MS) is an analytical approach in which predefined molecules—such as specific proteins, peptides, metabolites, or lipids—are selectively quantified or identified using a mass spectrometer. The method focuses on a limited set of known analytes rather than attempting comprehensive, untargeted profiling of all detectable species in a sample.

Principles

1. Selection of Analytes – Prior knowledge (e.g., from previous discovery experiments or hypothesis‑driven research) determines the list of target compounds.
2. Transition Monitoring – The mass spectrometer is programmed to monitor pre‑selected precursor‑product ion pairs (transitions) that uniquely identify each target.
3. Quantitation – Stable‑isotope‑labeled internal standards are frequently employed to achieve high‑precision absolute quantitation.
4. Instrument Modes – Commonly used acquisition modes include:
   • Selected Reaction Monitoring (SRM) / Multiple Reaction Monitoring (MRM) – Performed on triple‑quadrupole instruments; monitors one or more transitions per target.
   • Parallel Reaction Monitoring (PRM) – Conducted on high‑resolution instruments (e.g., Orbitrap, Q‑TOF); records full fragment spectra for each precursor, improving selectivity.
   • Scheduled Acquisition – Retention‑time windows are applied to reduce cycle time and increase the number of targets that can be monitored in a single run.

Typical Workflow

1. Assay Development – Choice of suitable peptides or metabolites, optimization of collision energies, and validation of chromatographic conditions.
2. Method Validation – Evaluation of parameters such as linearity, limit of detection (LOD), limit of quantitation (LOQ), precision, accuracy, and matrix effects.
3. Sample Preparation – Often includes protein digestion (for proteomics), extraction, and, when needed, enrichment steps.
4. Data Acquisition & Processing – Software tools extract ion chromatograms for the defined transitions and calculate analyte concentrations using calibration curves.

Applications

• Proteomics – Quantitative verification of biomarkers, measurement of enzyme activity, pharmacokinetic monitoring of therapeutic antibodies.
• Metabolomics – Targeted profiling of metabolites linked to disease states, nutritional studies, and drug metabolism.
• Clinical Diagnostics – Approved assays such as the measurement of newborn screening metabolites and therapeutic drug monitoring.
• Food Safety & Environmental Testing – Detection of contaminants (e.g., mycotoxins, pesticides) at trace levels.

Advantages

• High analytical specificity and sensitivity (often sub‑nanomolar).
• Robust quantitative performance with low inter‑run variability.
• Capability to multiplex dozens to hundreds of targets in a single run when using scheduled acquisition.
• Reduced data complexity compared with untargeted approaches, facilitating streamlined interpretation and regulatory compliance.

Limitations

• Prior knowledge of target analytes is required; novel or unexpected compounds are not discovered.
• Development time can be substantial for large panels, particularly when stable‑isotope standards are needed.
• Potential for interferences if transitions are not sufficiently unique, especially in complex biological matrices.

Related Concepts

• Untargeted (discovery) mass spectrometry
• Selected Reaction Monitoring (SRM) / Multiple Reaction Monitoring (MRM)
• Parallel Reaction Monitoring (PRM)
• Quantitative proteomics

References

• Aebersold, R., & Mann, M. (2003). Mass spectrometry-based proteomics. Nature, 422(6928), 198‑207.
• Gallien, S., et al. (2012). Targeted proteomics in the post‑genomic era: an overview of assays, methods and applications. Molecular & Cellular Proteomics, 11(10), 1419‑1439.
• Wang, M., et al. (2020). Targeted metabolomics: a powerful approach to study metabolism. Analytical Chemistry, 92(11), 7614‑7623.